Prediction: These 3 Stocks Will Crush the Market in 2026

These stocks all have catalysts on the way that could provide great news for investors.

I’ll readily admit that I don’t know how the stock market will perform in 2026. It could continue to climb. On the other hand, the momentum from last year could evaporate.

However, I think the individual stocks that outperform the S&P 500 (SNPINDEX: ^GSPC) this year will be those with key catalysts. With that in mind, I predict that three stocks will crush the market in 2026.

Image source: Getty Images.

1. Alphabet

Google parent Alphabet (GOOG 1.08%) (GOOGL 1.06%) has delivered tremendous gains over the last 12 months, even with a recent pullback. I expect the good times will keep rolling for the artificial intelligence (AI) stock this year.

Alphabet provided a big hint in its fourth-quarter update that bodes well for its near-term prospects. CFO Anat Ashkenazi mentioned that Google Cloud’s backlog soared by 55% quarter over quarter in Q4 and more than doubled year over year to $240 billion. As Google Cloud converts much of that backlog into recognized revenue throughout 2026, Alphabet’s earnings should grow significantly.

Alphabet Stock Quote

Today’s Change

(-1.06%) $-3.28

Current Price

$305.72

To put that backlog figure into context, Google Cloud’s annual revenue run rate at the end of 2025 was around $70 billion. There’s no mystery why the backlog has grown so much. Customers are flocking to Google Cloud’s enterprise AI products and services built on top of its powerful Gemini 3.0 AI models.

Agentic AI is another reason I think that 2026 could be a banner year for Alphabet. Google Antigravity, a development platform that uses AI agents to plan and execute complex software functions, is already a big hit with developers, only a few months after its launch. Google has embedded agentic AI into the Chrome browser. It’s also incorporating more powerful AI agents in tools for advertisers. My hunch is that we’ll see these investments begin to pay off in a visible way this year.

2. BeOne Medicines

Biotech stocks can usually be counted on to provide powerful catalysts over the course of a year. I think that BeOne Medicines (ONC +0.02%) could have three such catalysts in 2026.

BeOne, formerly known as BeiGene, already has a blockbuster drug in its lineup with Brukinsa. The blood cancer drug now ranks as the top BTK inhibitor in the market after steadily taking market share away from the previous top therapy, Imbruvica. BeOne could have more good news for Brukinsa soon. The company plans to announce results from a Phase 3 study evaluating Brukinsa in combination with rituximab as a first-line treatment for mantle cell lymphoma (MCL) in the first half of 2026.

BeOne Medicines Ag Stock Quote

Today’s Change

(0.02%) $0.07

Current Price

$346.49

While I expect continued momentum for Brukinsa over the next four quarters, it probably won’t be the biggest story for BeOne. Instead, that honor belongs to sonrotoclax. The company hopes to win U.S. regulatory approval for sonro for the treatment of relapsed or refractory MCL in the first half of this year.

Those aren’t the only potential catalysts for BeOne in 2026, though. The drugmaker could also file for accelerated approval of BGB-16673 for the treatment of relapsed or refractory chronic lymphocytic leukemia in the second half of the year, pending positive results from a Phase 2 clinical study.

3. Rhythm Pharmaceuticals

Rhythm Pharmaceuticals (RYTM +2.05%) is another biotech stock (in this case, a mid-cap stock) that I think could easily trounce the market in 2026. Rhythm currently markets only one product, Imcivree. The drug is approved for treating three rare genetic obesity disorders.

However, a fourth approved indication could be right around the corner. The U.S. Food and Drug Administration (FDA) is scheduled to announce its decision on the approval of Imcivree for the treatment of acquired hypothalamic obesity (HO) by March 20, 2026. Positive news would likely cause Rhythm’s shares to soar. Acquired HO affects more patients in the U.S. than the three already approved indications for Imcivree in the U.S. and European Union combined.

Rhythm Pharmaceuticals Stock Quote

Today’s Change

(2.05%) $1.97

Current Price

$98.03

Investors also have other catalysts to look forward to. Rhythm expects to report top-line data from a Phase 3 study evaluating Imcivree in four other genetic diseases in the first quarter of 2026.

The company plans to disclose six-month results from an exploratory Phase 2 study evaluating the drug for the treatment of Prader-Willi syndrome in the first half of the year. While Prader-Willi syndrome is rare, it affects around 400,000 people worldwide and therefore represents a significant market opportunity for Rhythm.

Source link

Visited 1 times, 1 visit(s) today

Related Article

Prediction: Micron’s Stock Could Reach $1,200 by the End of 2026

Micron Technology had an incredible run in 2025, but it’s just getting started. The market for artificial intelligence (AI) processors saw Nvidia become the world’s most valuable company, with its market cap even exceeding $5 trillion briefly in late 2025. But I think the next stage of the AI boom will benefit memory companies the

Why the ‘AI scare trade’ might not be done

New York  —  A sell-off rippled through software, real estate and trucking stocks this past week as investors worried artificial intelligence could upend some industries — and analysts say the white-knuckle drops might not be over yet. Software stocks bore the initial brunt of AI disruption nerves. But those fears soon spread to insurance companies,

How to Invest Amid AI Volatility: JPMorgan Shares Where to Hide Out

If you’re looking for a place to hide out in the stock market as AI continues to disrupt industry after industry, JPMorgan Asset Management says to look to the quality factor. “Quality” in this case isn’t a general term of approval. Quality stocks are those with strong and consistent cash flow and earnings, experienced management

Be ready for a violent stock market crash

Image source: Getty Images The stock market’s performed well recently. And looking ahead, most experts expect the good times to continue, given that economic growth is solid and artificial intelligence (AI) is enhancing productivity. However, there’s an issue on the horizon that’s starting to concern me. I’m worried that this could be the catalyst for

What To Expect From Genuine Parts’s (GPC) Q4 Earnings

Auto and industrial parts retailer Genuine Parts (NYSE:GPC) will be reporting earnings this Tuesday before the bell. Here’s what to look for. Genuine Parts beat analysts’ revenue expectations by 2.2% last quarter, reporting revenues of $6.26 billion, up 4.9% year on year. It was a satisfactory quarter for the company, with a solid beat of

Apple Stock Is Interesting, but Here’s What I’d Buy Instead

Apple stock has posted respectable gains on the market over the past six months, but its supplier partner has been a better investment. Shares of tech giant Apple (AAPL 2.20%) have clocked respectable gains of 11.6% on the market in the past six months, outpacing the 5.8% jump in the S&P 500 index over the

Prediction: The Trump Bull Market Will Soon Be Derailed, With This Historically Insurmountable Headwind Being the Culprit

Wall Street’s preeminent valuation yardstick offers a worrisome tale for investors. From an investment standpoint, Wall Street is a fan of Donald Trump in the White House. During President Trump’s first term in office, the mature stock-driven Dow Jones Industrial Average (^DJI +0.10%), benchmark S&P 500 (^GSPC +0.05%), and innovation-fueled Nasdaq Composite (^IXIC 0.22%) gained

The 1 Stock I’d Buy Before Interactive Brokers Group Right Now

Key Points Robinhood doubled its revenue amid new product offerings, strong demand for existing options, and more customers joining the platform. This winning combination is supported by soaring profit margins, demonstrating sustainable growth. Prediction markets are a hot segment for Robinhood that can become a sizable part of the business in a few years. Global

Forget Tariffs! Earnings Quality Is a Far More Sinister Worry for Wall Street.

Though President Donald Trump’s tariff and trade policy may garner the headlines, something more fundamental is at risk of derailing this high-flying stock market. The third year of Wall Street’s bull market rally didn’t disappoint. When the curtain closed last year, the S&P 500 (^GSPC +0.05%) had risen 16%, marking its third consecutive year of

Is the stock market open on Presidents Day? See 2026 holiday schedule.

Feb. 15, 2026, 3:00 p.m. ET U.S. stock markets will be closed on Monday, Feb. 16, in observance of Presidents Day. Presidents Day has been a federal holiday since 1879. It originally served to commemorate George Washington’s birthday but has since expanded to be a tribute to all presidents. Though the holiday is more commonly

Is Wall Street Wrong About Amazon Stock?

Shares of the technology giant have dipped after a massive spending push related to artificial intelligence. Investors know Amazon (AMZN 0.41%) as one of the best-performing stocks of the 21st century. However, the trillion-dollar technology giant has actually severely underperformed the stock market indexes in recent years. Amazon stock is up just 22% cumulatively in

Here’s Why JFrog Ltd (FROG) Price Target Was Raised To $78 by Baird

JFrog Ltd. (NASDAQ:FROG) is one of the 12 best mid cap AI stocks to buy according to hedge funds. On February 8, Robert W. Baird analyst Shrenik Kothari reaffirmed a Buy rating on JFrog Ltd. (NASDAQ:FROG) while increasing the firm’s price target on the stock from $70 to $78. He cited the company’s strong growth

If a Stock Market Crash Is Coming, This 1 Investing Move Is Critical Right Now

Here’s exactly how to protect your portfolio against market volatility. Stock prices have been stumbling in recent weeks, and investors have mixed feelings about the future of the market. While 38.5% of investors feel optimistic about the next six months, according to the most recent weekly survey from the American Association of Individual Investors, 38.1% worry

1 Powerhouse Growth Stock I’d Happily Hold Through Any Market Crash

Given the importance of the AI buildout, Broadcom’s semiconductor chips make the stock a top pick under any economic conditions. Stock market crashes rattle most investors, as they are the ultimate tests of patience and willpower. Some people abandon high-quality companies if they drop by 10%, only to regret that decision when those same corporations

3 Tech Stocks With More Potential Than Any Cryptocurrency

These stocks have a lot of upside — and much less downside risk than the crypto market. The problem (or the opportunity, depending on your point of view) with cryptocurrencies is their massive volatility. Because most cryptocurrencies lack a fundamental valuation floor or metrics like stocks — price-to-earnings ratio or cash flow, for instance —

0
Would love your thoughts, please comment.x
()
x